To investigate factors influencing prognosis in medication-overuse headache (MOH), we conducted a 12-month follow-up of patients with probable MOH. We recruited 215 patients consecutively admitted to our headache centre for an inpatient detoxification treatment. We analysed likely predictor factors for headache resolution (sex, age, primary headache, psychiatric comorbidity, type and timing of overuse). Mann-Whitney U-test and chi-squared test were used. One year after withdrawal, we had complete data on 172 patients (80%): 38 of these patients (22%) had relapsed into overuse and 134 (78%) had not. The negative prognostic factors for relapse were: intake of more than 30 doses/month (P=0.004), smoking (P=0.012), alcohol consumption (P=0.037), non-confirmation of MOH diagnosis 2 months after detoxification (P=0.000), and return to overused drug(s) (P=0.000). The 1-year relapse rate was 22%. The existence of sub-groups of MOH patients with such risk factors could influence treatment strategies.

Risk factors in medication-overuse headache: A 1-year follow-up study (care II protocol) / G., Sancez; G., Sances; N., Ghiotto; Galli, Federica; E., Guaschino; C., Rezzani; Guidetti, Vincenzo; G., Nappi. - In: CEPHALALGIA. - ISSN 0333-1024. - 30:3(2010), pp. 329-336. [10.1111/j.1468-2982.2009.01934.x]

Risk factors in medication-overuse headache: A 1-year follow-up study (care II protocol)

GALLI, FEDERICA;GUIDETTI, Vincenzo;
2010

Abstract

To investigate factors influencing prognosis in medication-overuse headache (MOH), we conducted a 12-month follow-up of patients with probable MOH. We recruited 215 patients consecutively admitted to our headache centre for an inpatient detoxification treatment. We analysed likely predictor factors for headache resolution (sex, age, primary headache, psychiatric comorbidity, type and timing of overuse). Mann-Whitney U-test and chi-squared test were used. One year after withdrawal, we had complete data on 172 patients (80%): 38 of these patients (22%) had relapsed into overuse and 134 (78%) had not. The negative prognostic factors for relapse were: intake of more than 30 doses/month (P=0.004), smoking (P=0.012), alcohol consumption (P=0.037), non-confirmation of MOH diagnosis 2 months after detoxification (P=0.000), and return to overused drug(s) (P=0.000). The 1-year relapse rate was 22%. The existence of sub-groups of MOH patients with such risk factors could influence treatment strategies.
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/421395
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 16
  • Scopus 50
  • ???jsp.display-item.citation.isi??? 47
social impact